R1 RCM Inc

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

R1 RCM Inc (RCM) posts strong Q4 results, eyes Cloudmed growth

R1 RCM Inc (RCM) delivered robust financial performance in Q4 2022, focusing on operational excellence, technology investments, and customer engagement. Challenges include integration efforts and seasonality affecting incentive fees. The company is poised for growth with opportunities in Cloudmed expansion and AI utilization.

R1 RCM Inc (RCM) reports strong Q1 results and growth opportunities

R1 RCM Inc (RCM) delivered strong Q1 results, with a focus on operational improvements, robust Cloudmed growth, and positive financial outlook for 2023.
The company showcased resilience in stable patient self-pay trends, improving payer reimbursement timelines, and strategic capacity for onboarding new NPR, positioning itself for continued success.
Challenges include industry financial pressures, sustaining growth in legacy business, and managing operational costs effectively, requiring strategic adaptation and continuous innovation.
Opportunities lie in pipeline visibility for deals, sequential EBITDA growth, integration of Cloudmed capabilities, and strategic onboarding plans, offering avenues for expansion and profitability.

R1 RCM Inc reports robust Q2 earnings, eyes growth opportunities

R1 RCM Inc's Q2 performance was strong, with a focus on technology and operational enhancements. Challenges include revenue adjustments and workforce implications of automation. Opportunities lie in improved payer dynamics and growth through physician market focus and cross-selling.

R1 RCM Inc reports robust Q3 performance and eyes growth

R1 RCM Inc's Q3 earnings call highlighted strong financial performance, strategic priorities, and challenges in pediatric contracts and integration issues.
The company's focus on revenue optimization, leveraging technology, and partnership with Microsoft positions it well for growth opportunities within the customer base and offshoring initiatives.
While facing challenges in deal timings and debt repayment, R1 RCM Inc's emphasis on operational metrics, customer relationships, and workforce management presents avenues for continued success and industry leadership.

R1 RCM Inc reports robust Q4 earnings, eyes growth opportunities

R1 RCM Inc's Q4 2023 earnings call highlighted strong financial performance, strategic objectives for 2023, and a confident outlook for sustainable growth and shareholder value creation.
The company's emphasis on customer-centricity, AI integration, and operational efficiency underscores its strengths in revenue growth and market positioning.
While facing challenges in credit allowances and customer health, R1 RCM Inc aims to leverage opportunities in reduced costs, synergies from acquisitions, and strategic sales to drive future growth.

R1 RCM reports resilient Q1 performance post-cyberattack, eyes growth

R1 RCM showcased resilience in Q1 2024 despite the Change Healthcare cyberattack, focusing on growth strategies, operational excellence, and technology innovation.
The company faces challenges from the cyberattack impact on KPIs and vendor changes but sees opportunities in the managed care environment and customer engagement.
Overall, R1 RCM remains optimistic about transforming the industry through technology and expertise, with a strong market demand for its solutions.

R1 RCM Inc reports robust Q2 earnings amidst cyberattack challenges

R1 RCM Inc's Q2 2024 earnings call showcased strong financial performance, operational resilience in the face of cyberattacks, and a strategic focus on growth initiatives. The company faces challenges related to pending transactions and cyberattack impacts but sees opportunities in expanding its platform and leveraging technology for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CHICAGO, July  21, 2020  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2020 before market open on Tuesday, August 4, 2020.

R1 RCM to Release Second Quarter 2020 Results on August 4

Creates Preferred Business Model to Drive Superior Revenue Cycle Results Creates Preferred Business Model to Drive Superior Revenue Cycle Results

R1 Announces Agreement to Acquire Cerner RevWorks℠

CHICAGO, June  01, 2020  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, announced Pinnacle Dermatology, one of the most prominent multi-state leaders in population skin health management, has selected R1’s revenue cycle management solution to help improve performance, lower costs and increase patient satisfaction.

R1 Drives Continued Growth in Physician Revenue Cycle Management Market with Addition of Pinnacle Dermatology

R1 RCM Inc. (RCM) CEO Joe Flanagan on Q1 2020 Results - Earnings Call Transcript

CHICAGO, May  04, 2020  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the appointment of Rachel Wilson as Executive Vice President, Chief Financial Officer and Treasurer effective June 1, 2020.

R1 RCM Appoints Rachel Wilson as Executive Vice President and Chief Financial Officer

CHICAGO, April  30, 2020  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management services to healthcare providers, announced today that Penn State Health, a multi-hospital academic health system in central Pennsylvania, has entered into a five-year strategic partnership with R1. 

Penn State Health Selects R1 RCM for End-to-End Revenue Cycle Management to Drive Performance Excellence

CHICAGO, April  01, 2020  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it has completed the acquisition of SCI Solutions, Inc. (SCI).

R1 Completes Acquisition of SCI Solutions

R1 RCM Inc. (RCM) CEO Joseph Flanagan on Q4 2019 Results - Earnings Call Transcript

Solution provides a standardized RCM operational strategy across all care settings and reimbursement models to deliver superior financial outcomes. Solution provides a standardized RCM operational strategy across all care settings and reimbursement models to deliver superior financial outcomes.

R1 RCM Expands Market Reach with Launch of Revenue Cycle Management Solution for Large Physician Groups

Acquisition adds robust digital front door capabilities to R1’s technology platform, enabling healthcare providers to automate ordering, scheduling, and authorization processes Acquisition adds robust digital front door capabilities to R1’s technology platform, enabling healthcare providers to automate ordering, scheduling, and authorization processes

R1 Announces Agreement to Acquire SCI Solutions, a Leading Provider of Digital Patient Engagement Solutions

CHICAGO, Jan.  09, 2020  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, announced today that Rush University System for Health (RUSH) has entered into a strategic partnership to achieve revenue cycle performance excellence and accelerate innovation in healthcare.  RUSH, an academic health system, is a nationally recognized leader in the delivery of high-quality care and the use of information technology to achieve better outcomes, lower costs and improve the patient experience.

Rush University System for Health Selects R1 RCM for End-to-End Revenue Cycle Management to Drive Performance Excellence and Accelerate Innovation

R1 RCM, Inc. (RCM) CEO Joseph Flanagan on Q3 2019 Results - Earnings Call Transcript

CHICAGO, Oct.  29, 2019  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the appointment of Vijay Kotte as Executive Vice President of Physician Services.

R1 RCM Appoints Vijay Kotte as Executive Vice President, Physician Services

CHICAGO, Sept.  30, 2019  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the company will present at the Cantor Fitzgerald 2019 Global Healthcare Conference on Friday, October 4, 2019 at 9:30 am Eastern Time.

R1 RCM to Present at the Cantor Fitzgerald 2019 Global Healthcare Conference

CHICAGO, Aug.  19, 2019  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019 at 12:15 pm Eastern Time.

R1 RCM to Present at the Baird 2019 Global Healthcare Conference

R1 RCM, Inc. (RCM) CEO Joseph Flanagan on Q2 2019 Results - Earnings Call Transcript

R1 RCM Inc. (RCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

R1 RCM Inc. (RCM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

R1 RCM, Inc. (RCM) CEO Joseph Flanagan on Q1 2019 Results - Earnings Call Transcript

News for R1 RCM Inc Stock (RCM)